Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH study

被引：0
|
作者：
Christine R Jenkins
Paul W Jones
Peter MA Calverley
Bartolome Celli
Julie A Anderson
Gary T Ferguson
Julie C Yates
Lisa R Willits
Jörgen Vestbo
机构：
[1] Woolcock Institute of Medical Research,Division of Cardiac and Vascular Science, St George's
[2] University of London,undefined
[3] University Hospital,undefined
[4] St Elizabeth's Medical Centre,undefined
[5] GlaxoSmithKline (GSK),undefined
[6] Pulmonary Research Institute of Southeast Michigan,undefined
[7] GSK,undefined
[8] Wythenshawe Hospital,undefined
[9] Hvidovre Hospital,undefined
来源：
Respiratory Research | / 10卷
关键词：
Chronic Obstructive Pulmonary Disease; Chronic Obstructive Pulmonary Disease Patient; Fluticasone Propionate; Salmeterol; Severe Chronic Obstructive Pulmonary Disease;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH study
    Jenkins, Christine R.
    Jones, Paul W.
    Calverley, Peter M. A.
    Celli, Bartolome
    Anderson, Julie A.
    Ferguson, Gary T.
    Yates, Julie C.
    Willits, Lisa R.
    Vestbo, Joergen
    RESPIRATORY RESEARCH, 2009, 10
  • [2] Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease
    Paggiaro, PL
    Dahle, R
    Bakran, I
    Frith, L
    Hollingworth, K
    Efthimiou, J
    LANCET, 1998, 351 (9105): : 773 - 780
  • [3] Efficacy and Safety Analysis of Salmeterol/Fluticasone Propionate with Tiotropium Bromide for Chronic Obstructive Pulmonary Disease
    Zhang, Zili
    INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2024, 86 : 128 - 133
  • [4] Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease
    Calverley, Peter M. A.
    Anderson, Julie A.
    Celli, Bartolome
    Ferguson, Gary T.
    Jenkins, Christine
    Jones, Paul W.
    Yates, Julie C.
    Vestbo, Jorgen
    Calverley, P. M. A.
    Anderson, J. A.
    Celli, B.
    Ferguson, G. T.
    Jenkins, C.
    Jones, P. W.
    Knobil, K.
    Yates, J. C.
    Vestbo, J.
    Cherniack, R.
    Similowski, T.
    Cleland, J.
    Whitehead, A.
    Wise, R.
    McGarvey, L.
    John, M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (08): : 775 - 789
  • [5] Fluticasone propionate/salmeterol for the treatment of chronic-obstructive pulmonary disease
    Dransfield, MT
    Bailey, WC
    EXPERT OPINION ON PHARMACOTHERAPY, 2004, 5 (08) : 1815 - 1826
  • [6] Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial
    Calverley, P
    Pauwels, R
    Vestbo, J
    Jones, P
    Pride, N
    Gulsvik, A
    Anderson, J
    Maden, C
    LANCET, 2003, 361 (9356): : 449 - 456
  • [7] Impact of salmeterol/fluticasone propionate versus salmeterol on exacerbations in severe chronic obstructive pulmonary disease
    Kardos, Peter
    Wencker, Marion
    Glaab, Thomas
    Vogelmeier, Claus
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2007, 175 (02) : 144 - 149
  • [8] Early onset of effect of salmeterol and fluticasone propionate in chronic obstructive pulmonary disease
    Vestbo, J
    Pauwels, R
    Anderson, JA
    Jones, P
    Calverley, P
    THORAX, 2005, 60 (04) : 301 - 304
  • [9] Salmeterol/Fluticasone Propionate (SFC) Is Efficacious in GOLD Stage II COPD Patients: Analysis from the TORCH Study.
    Jenkins, C.
    Celli, B.
    Anderson, J.
    Ferguson, G.
    Calverley, P.
    Jones, P.
    Yates, J.
    Willits, L.
    Vestbo, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [10] Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease (vol 351, pg 773, 1998)
    Paggiaro, PL
    LANCET, 1998, 351 (9120): : 1968 - 1968
12345